Juvenile sea bream were fed on diets containing 0.0, 2.0 or 4.0 g kg À 1 of a soybean trypsin inhibitor (SBTI) for 30 days. The growth performance, total protease activity and intestinal histology were studied after 0, 15 and 30 days of dietary treatment. No signi¢cant di¡erences were found in the weight gain, speci¢c growth rate (SGR) and feed conversion rate in ¢sh fed on inhibitor-supplemented diets when compared with those fed on an inhibitor-free diet. Only the SGR at day 15 decreased signi¢cantly with protease inhibitor inclusion, although this e¡ect was not observed at day 30. In relation to proteolytic activity at day15, the total protease activity in the distal intestine decreased in ¢sh fed on inhibitor-supplemented diets. Zymograms of these extracts showed that the SBTI reduced the intensity of some proteolytic fractions in the distal intestine. A noticeable reduction in the protease activity of the intestinal content in ¢sh fed on the highest level of soybean inhibitor (4.0 g kg
Introduction
A growing limitation of ¢sh meal supplies is leading to the search for alternative protein sources for aquafeeds. Plant protein ingredients are reasonably priced, and have been widely studied due to their current worldwide distribution and steady supply. Soybean meal is the most commonly used plant protein in aquafeeds because its amino acid composition meets ¢sh amino acid requirements (Lim & Akiyama 1992) . However, ¢sh meal replacement by soybean meal presents certain challenges, such as the reduction in some e¡ects caused by antinutritional factors present in this plant protein source (Francis, Makkar & Becker 2001) , which may limit its use in diets for carnivorous ¢sh species (Makkar 1993) .
Soybean meal antinutritional factors can impair digestion processes (Kissil, Lupatsch, Higgs & Hardy 2000) by binding protease inhibitors to digestive enzymes (Moyano, Mart|¤ nez, D|¤ az & Alarco¤ n 1999) or by the formation of phytic acid^protein complexes (Richardson, Higgs, Beames & McBride1985) . The use of soybean has also been related to hypocholesterolaemia (Kaushik, Cravedi, Lalles, Sumpter, Fauconneau & Laroche 1995) , hepatic hypertrophy and induced vitellogenesis (Pelissero, Bennetau, Babin, Lemenn & Dunogues 1991) or intestinal lesions (Refstie, Korson, Storebakken, Baeverfjord, Lein & Roem 2000) . Furthermore, these e¡ects may lead to reduced growth performance ratios, as described for sea bream (Kissil et al. 2000) , rainbow trout (Ostaszewska, Dabrowski, Palacios, Olejniczak & Wieczorek 2005) or tilapia (El-Sayed, Mart|¤ nez & Moyano 2000) .
In any event, studies related to soybean inclusion e¡ects on ¢sh metabolism and growth performance are controversial, because the inclusion of soybean meal in ¢sh diets reduced growth performance in some trials (Dabrowski, Poczyczynski, Kock & Berger 1989; Gallagher 1994; Gomes, Rema & Kaushik 1995; El-Sayed et al. 2000) , while in others, the speci¢c growth rate (SGR) was maintained (Sanz, Morales, de la Higuera & Cardenete 1994; Kaushik et al. 1995; Bonaldo, Roem, Fagioli, Pecchini, Cipollini & Gatta 2008) or even improved (Oliva-Teles, Gouveia, Gomes & Rema 1994) . This variation in the results can be explained by di¡erences in the size of the animals (Choi, Wang, Park, Lim, Kim, Bai & Shin 2004; Venou, Alexis, Fountoulaki & Haralabous 2006) , plant protein inclusion levels (Krogdahl, Lea & Olli 1994; Robaina, Izquierdo, Moyano, Socorro, Vergara, Montero & Ferna Ł ndez-Palacios 1995; Olsen, Hansen, Roselund, Hemre, Mayhew, Knudsen, Eroldogan, Myklebust & Karlsen 2007 ) and species-speci¢c sensitivity to alternative raw sources (Krogdahl & Holm 1983; Moyano et al. 1999 ; Alarco¤ n, Garc|¤ a-Carren ì o & Navarrete del Toro 2001) . It may also depend on the origin and treatment of the soybean meal source used in each case (Refstie, Storebakken & Roem1998; Francis et al.2001) .
Biochemical and histological alterations described in ¢sh meal replacement trials are attributed to residual antinutritional factors present in soybean meal or soybean derivates used in experimental diets. However, there is scarce information about the role of speci¢c soybean meal antinutritional factors involved in each speci¢c alteration (Krogdahl et al. 1994; Olli, Hjelmeland & Krogdal 1994; Refstie et al. 2000) . It should be remembered that most antinutritional factors described can be eliminated from raw materials by using di¡erent technological processes (Francis et al. 2001) . Nevertheless, some of them are heat-stable, and may a¡ect digestion processes when only conventional treatments are undertaken, such as the Bowman^Birk protease inhibitor (Alarco¤ n, , soya saponins (Knudsen, Ron, Baardsen, Smedsyaard, Koppe & Frokiaer 2006) or phytic acid (Anderson & Wolf 1995) . Moreover, synergism has been described between lectins, commonly present in legume seeds, and other antinutritional factors (Grant 1991) .
As only a few studies have analysed the speci¢c effects of each antinutritional factor in detail (Krogdahl et al. 1994; Olli et al. 1994; Sveier, Kuamme & Raae 2001) , the study of e¡ects related to individual antinutritive compounds on ¢sh physiological processes is of interest. Such studies are needed in order to elucidate their consequences, and to collect the necessary information to minimize their e¡ects when ¢sh are fed on diets containing plant protein ingredients.
Di¡erences in the results from previous studies involving diets containing soybean meal, together with in vitro studies proving inhibition of digestive proteases by soybean meal extracts , make it necessary to study the in vivo consequences when juvenile sea bream are fed on diets containing soybean-puri¢ed antinutritional factors.
The present study was developed to evaluate the effects on growth performance, digestive protease activity and intestine morphology of gilthead sea bream fed on puri¢ed soybean trypsin inhibitor (SBTI)-supplemented diets during a mid-term trial.
Materials and methods

Animals
One hundred and eighty-nine living sea bream (Sparus aurata) ¢ngerlings obtained from a commercial farm (Predomar S.L., Almer|¤ a, Spain) were acclimatized in an indoor marine water system. Fish were fed on a commercial diet (Skretting 2 mm, 45% protein, 12% lipid) before the onset of the experiment. After 15 days, the ¢sh (13.5 AE 0.14 g) were randomly distributed into nine experimental tanks (50 L; 21 ¢sh per tank) connected to a closed recirculating system consisting of a mechanical sand ¢lter, ultraviolet lights and a bio¢lter. The system was maintained at a constant temperature (21 AE 1 1C), a constant salinity (30 AE 2 ppm) and a 12 h:12 h light:dark photoperiod. Water quality was maintained by physical ¢lters and UV radiation. The total ammonia concentration was measured daily and did not exceed 0.2^0.3 mg L trypsin inhibitor (SBTI-93620, 10 000 U mg À 1 ; Sigma-Aldrich, Madrid, Spain), was repelleted (2 mm) to obtain diet control, SBTI-1 and SBTI-2 respectively. Diet samples were collected to measure protease inhibitor activity and stored at À 20 1C.
During the feeding trial, three triplicate groups of ¢sh were fed 4% of tank biomass of the corresponding experimental diet twice a day (09:00 and 16:00 hours) for 30 days. After this period, the remaining ¢sh in the three treatments were fed on the control diet for an additional period of 10 days, to determine whether any possible e¡ects of SBTI on the growth rates or intestinal histology could be reversed by the administration of an inhibitor-free diet.
Protease inhibitor activity in diets
The inhibitory e¡ect of experimental feeds (control, SBTI-1 and SBTI-2) on digestive sea bream acid and alkaline proteases of the initial samples (S0) was evaluated according to Alarco¤ n et al. (2001) . Twenty microlitres of a dilution series of feed extracts (providing amounts of experimental diet that ranged from 0 to 20 mg) were incubated with 20 mL of enzymatic extracts providing a ¢xed amount of activity (digestive extracts had been adjusted previously to provide a 0.5 increase of absorbance at 280 nm in 30 min at 25 1C) in 0.5 mL of 0.1M glycine^HCl pH 2.0 (for acid proteases) or 50 mM Tris-HCl pH 9.0 (for alkaline proteases) for 1h at 25 1C. After that, the residual protease activity was evaluated by adding 0.5 mL of substrate (haemoglobin or casein for acid and alkaline proteases respectively). Controls were prepared by adding the equivalent amount of distilled water instead of aqueous feed extracts. Enzyme inhibition was assessed as the percentage of residual activity by comparing it with the control assay. Porcine trypsin (Sigma-Aldrich T-0303; 13000^20 000 U mg À 1 protein) was included as an internal control in the inhibition assay.
Sampling
During the growth trial, four samplings were carried out at days 0, 15, 30 and 40 (S0, S15, S30 and S40 respectively) and individual ¢sh weight was recorded in 12-h starved ¢sh. The next day, after S0, S15 and S30 ¢sh weight determination, additional samplings were performed 3 h after manual feeding to obtain ¢sh digestive tissues. Four animals per tank were randomly selected and sacri¢ced according to the requirements in Council Directive 86/609/EEC after isoeugenol overdose (clove oil), then weighed and measured.Viscera (including the liver and the digestive tract) were removed and also weighed. Complete digestive tracts were then obtained, measured, emptied of intestinal content (IC) by scrapping and divided into the stomach (ST), proximal intestine (PI, including pyloric caeca) and distal intestine (DI) segments. These three segments (ST, PI and DI) and the IC were rapidly frozen ( À 80 1C) for later enzyme analysis. Additionally, from S0 to S40, for one ¢sh per tank (three ¢sh per treatment), proximal (placed 2 cm from the stomach) and distal (placed 2 cm before the anal ori¢ce) intestinal portions (0.5 cm of length) were stored in 4% bu¡ered formalin (pH 7.2) for histological analysis.
Zootechnical indices
The SGR was calculated as SGR 5 [100 Â (ln W ¢n À ln W in )]/t, where W ¢n and W in stand for the ¢nal and the initial weight (tank means), respectively, and t stands for the feeding time (days). The feed conversion rate (FCR) was calculated as FCR 5 gram feed given per gram live weight gain. The visceral index (VI) was calculated as VI 5 (gram visceral weight per gram body weight) Â 100 and relative intestinal length (RIL) as RIL 5 intestinal length (cm) per gram body weight.
Preparation of enzyme extracts
Enzyme extracts were obtained by manual homogenization of individual samples (S0, S15 and S30) in distilled water (1:3 w/v for the IC and stomach and 1:2 w/v for the proximal and distal intestine). The supernatants obtained after centrifugation (16 000 g, 15 min, 4 1C; EBA 12 R, Genesys Instrumentation S.L., Madrid, Spain) were stored at À 20 1C for further enzymatic analysis.
Protease activity in digestive extracts
Acid^protease activity in the stomach and alkalinep rotease activity in the proximal and distal intestinal extracts were measured as described by Alarco¤ n, D|¤ az, Moyano and Abella Ł n (1998) . Brie£y, acid protease activity was measured by using 5 g L À 1 haemoglobin in 0.1M glycine^HCl (pH 2.0), while alkaline protease activity was determined by using 5 g L À 1 casein in 50 mM Tris-HCl (pH 9.0). Samples were incubated for 30 min at 25 1C and reactions were stopped by adding 0.5 mL of TCA (20%). The increase in supernatant absorbance was recorded at 280 nm in a spectrophotometer (Ultrospec 3300 pro; Amersham Pharmacia-Biotech, Cambridge, UK). All measures were performed in triplicate, and the blank for each sample was established by the addition of TCA before enzyme extract. One unit of enzyme activity was de¢ned as 1 mg of tyrosine released per minute. Activity was referred to wet sample weight as units per gram of digestive tissue or per gram of the IC respectively.
E¡ects of diet on protease-active fractions
Intestinal enzyme extracts were mixed with SDS sample bu¡er (1:1) and SDS-PAGE were performed according to Laemmli (1970) using 12% polyacrylamide (100 V per gel, 45 min, 4 1C). Zymograms revealing protease active bands were carried out according to Garc|¤ a-Carren ì o, Dimes and Haard (1993) . Thus, after electrophoresis, gels were washed and incubated in 5 g L À 1 casein at 4 1C. After 30 min, fresh casein was used and the temperature was increased (90 min, 37 1C). Gels were stained in methanol:acetic-acid: water (40:10:50) containing 1g L À 1 Coomassie brilliant blue, and were washed using the same solution without a colorant. Gel images were scanned using Universal Hood II (Bio-Rad, Segarte, Italy).
Intestine histology
Samples for histological evaluation of the intestinal tract were immersed in phosphate-bu¡ered formalin (4%, pH 7.2). The samples were subsequently dehydrated and embedded in para⁄n according to standard histological techniques. Sections of 5 mm were stained with haematoxylin^eosin and examined under light microscopy. A digital camera CC 12 (Soft Imaging System; Muenster, Germany) coupled to an Olympus BX40 light microscope was used to obtain images, and ANALYSIS software (Soft Imaging System) was then used. Intestinal morphology and di¡erences among treatments were evaluated according to the criteria suggested by Krogdahl, Bakke-Mckellep and Baeverfjord (2003) : (1) loss of supranuclear vacuolization on enterocytes in the intestinal epithelium, (2) widening of the central lamina propria within intestinal folds and (3) in¢ltration of leucocytes in lamina propria and submucosa. These alterations are characteristic in salmonids after enteritis induction through the inclusion of soybean meal in aquafeeds (Lilleeng, Froystad, Ostby,Valen & Krogdahl 2007 ).
Statistical analysis
Values are mean AE SEM (standard error of the mean) of at least three replicate determinations. All data presented a normal distribution (P40.05 in the Kolmogorov^Smirnov test), and were subjected to oneway ANOVA. Di¡erences between means at Po0.05 were analysed using the Tukey test. SPSS 12.0 software application (SPSS, IL, USA) was used to perform the analyses.
Chemicals
All reagents were purchased from Sigma-Aldrich.
Results
The presence of SBTI in the experimental diets was con¢rmed by an in vitro inhibition assay. Neither porcine trypsin nor intestinal proteases in sea bream were inhibited by the control diet (Fig. 1) . Both SBTI-1 and SBTI-2 diets inhibited commercial trypsin and ¢sh intestinal proteases, but no di¡erences were found between both diets. Acid proteases of sea bream were not a¡ected by SBTI at any of the experimental levels tested (Fig. 1b) .
No mortality was reported during the trial, and gilthead sea bream consumed all the experimental diets. Fish doubled their initial body weight, showing no signi¢cant di¡erences in the ¢nal weight and SGR between groups at days 30 and 40 (Table 2) . However, ¢sh fed on SBTI-supplemented diets showed lower SGR after 15 days of dietary treatment (S15). No signi¢cant di¡erences in FCR, VI or RIL were found for any of the tested diets.
At day 15, acid protease activity in the stomach showed no di¡erences between the control and the SBTI-1 groups (Fig. 2, S15 ), but ¢sh fed on the SBTI-2 diet presented the highest proteolytic activity in this intestinal segment (Po0.05). On the other hand, acid protease activity at day 30 (S30) revealed maximum activity in the control group, which progressively decreased when the amount of SBTI in the diet increased (up to À 46.6% in SBTI-2 ¢sh; Po0.05). Figure 3 shows the alkaline protease activity measured in the PI, DI and IC at day 15 (S15). This activity was not modi¢ed in the proximal intestine when the diet contained SBTI at either of the two tested concentrations, but it was signi¢cantly reduced in the distal intestine of ¢sh fed on inhibitor-supplemented diets. Protease activity in the IC decreased signi¢-cantly only in ¢sh fed on the SBTI-2 diet (Fig. 3, S15 ). These biochemical ¢ndings are supported by the SDS-PAGE results (Fig. 4a) . The zymogram shows that SBTI-supplemented diets produced a slight reduction in proteolytic activity in the proximal intestine (Fig. 4a, PI, lanes 2 and 3) . This zymogram illustrates that the inhibitor formed high-molecular-weight reversible complexes with intestinal proteases (asterisks show protease-inhibitor complexes over 94 kDa). However, the inhibition pattern for the distal intestine extracts (Fig. 4a , DI, lanes 5 and 6) was similar to that obtained when sea bream proteases were incubated with puri¢ed SBTI (Fig. 4c, lane 2) . In those extracts, both the formation of higher-molecularweight complexes (asterisks) and the almost complete inhibition of the two proteolytic fractions over 45 kDa (white arrows) were observed (Fig. 4a, lanes  5 and 6) . On the other hand, substrate-SDS-PAGE of the IC of ¢sh fed on SBTI-supplemented diets showed the presence of high-molecular-weight complexes ( Fig. 4a ; asterisks in lanes 8 and 9). 2, PI SBTI-1; 3, PI SBTI-2; 4, DI control; 5, DI SBTI-1; 6, DI SBTI-2; 7, IC control; 8, IC-SBTI-1; 9, IC-SBTI-2. Figure 1C shows the zymogram of the proximal intestine extracts of ¢sh feed on the control diet (1, PI control) and the zymogram obtained after a 1-h incubation of these extracts with puri¢ed SBTI (2, PI control 1 5 mg of SBTI). All samples are loaded in equal amounts (5 mL of enzymatic extracts). The apparent molecular size is indicated in kilodalton (kDa). Asterisks ( Ã ) denote reversible proteaseinhibitor complexes of high molecular weight and white arrows denote active fractions inhibited by SBTI.
At day 30, alkaline protease activity in the PI showed no di¡erences between the control and the SBTI-1 groups, but ¢sh fed on the SBTI-2 diet showed a signi¢-cant increase in their activity (about 27%) (Po0.05) (Fig. 3, S30) . Protease activity in the DI was similar in the three experimental groups (P40.05). In the case of the IC, ¢sh fed on the SBTI-1 diet showed the highest proteolytic activity (Po0.05). The zymogram (Fig. 4b) revealed the same qualitative pro¢le for active fractions at day 30. Figure 3 shows that proteolytic activity presented signi¢cant di¡erences between the intestinal segments, with the IC presenting the highest values, followed by those in the DI and, ¢nally, in the PI. Additionally, the intestinal extracts showed di¡erences in their proteolytic activities between the sampling points (S0, S15 and S30). Thus, protease activity in PI reduced signi¢cantly in S30 when compared with the S15 and S0 (1.54 AE 0.65 U mg À 1 tissue) values.
The same pattern was observed for the distal intestine (for SO, DI activity 5 2.54 AE 1.15 U mg À 1 tissue).
On the other hand, the IC activity decreased signi¢-cantly only in ¢sh fed on the SBTI-2 diet at the S15 sampling point (for S0, IC activity 5 4.93 AE 1.71 U mg À 1 tissue).
Histological intestine observation revealed no noticeable di¡erences in the appearance of the proximal or the distal intestine between the three experimental groups at any of the sampling times (Fig. 5) , or at the end of the additional 10-day period (S40; data not shown). Integrity was good in both intestinal segments, and a close approximation of cells with a minimal number of intraepithelial lymphocytes was observed. The lamina propria (lp) appears as a thin layer and cell in¢ltration was moderate. Di¡erentiated enterocytes, showing a basal nucleus (n), were present along mucosal folds. Intestinal mucosal cells showed a regular shape and well-vacuolated upper (snv), with well-de¢ned microvillar brush borders (mv). Goblet cells (gc) were regularly dispersed throughout the epithelium. Submucosa in SBTI-1 and SBTI-2 groups showed no abnormalities and was identical to that in the control group (data not shown).
Discussion
Commercial soybean products mainly report trypsin inhibitor activity (TIA) ranging between 2.0 and 6.0 g kg À 1 (Francis et al. 2001) . In the present study, the inclusion of up to 4.0 g kg À 1 of puri¢ed SBTI in diet caused no di¡erences in the ¢nal weight or the SGR after 30 days. No decrease in weight gain was likewise observed in other studies in which raw soybean meal (rich in protease inhibitors) was used for sea bream aquafeeds (Robaina et al. 1995; Venou et al. 2006) . Moreover, Sveier et al. (2001) demonstrated a positive e¡ect on growth performance when small amounts of protease inhibitor were included in the diet of Atlantic salmon. On the contrary, reduction in the growth performance and nutrient digestibilities had been reported previously in salmonids fed on diets containing puri¢ed SBTI at levels below 5 g kg À 1 in other trials (Krogdahl et al. 1994; Olli et al. 1994) . The ¢nal FCR,VI and RIL were also unaffected when diets were supplemented with puri¢ed SBTI. In a similar way, Sveier et al. (2001) did not ¢nd any FCR changes when protease inhibitors were included (up to 5 g kg
) in the diet of Atlantic salmon during a 21-day feeding period. By contrast, Peres, Lim and Klesus (2003) reported higher hepatosomatic and viscerosomatic indices in channel cat¢sh when the trypsin inhibitor content in their feed was increased. Santigosa, Sa Ł nchez, Me¤ dale, Kaushik, Pe¤ rez-Sa Ł nchez and Gallardo (2008) also reported an increment in the RIL when diet digestibility decreases due to the presence of plant protein sources.
The reduction in protease activity detected in the distal intestine and IC of ¢sh fed on SBTI-supplemented diets at day 15 may be related to the presence of a soybean inhibitor, which inhibits serine proteases through the formation of high-molecular-weight protein complexes (Fig. 4a, lanes 2 and 3) . This fact was demonstrated previously by in vitro assays Moyano et al. 1999) and it could be responsible for the decrease in the intestinal protease activity in sea bream or other ¢sh species when diets contain plant protease inhibitors (Krogdahl et al. 1994; Robaina et al. 1995; Venou, Alexis, Fountoulaki, Nengas, Apostolopoulou & Castritsi-Cathariou 2003; Lilleeng et al. 2007) . The reduction in the protease activity in the IC on increasing the inhibitor in the diet (SBTI-2) agrees with the results obtained by Olli et al. (1994) . These authors reported that the reduction observed in the proteolytic activity on increasing dietary SBTI seemed negligible at lower levels (1.05 g kg À 1
) but this inhibitory e¡ect increased considerably at higher levels (4.20 g kg
). However, results at day 30 showed that sea bream juveniles were able to increase protease secretion into the intestinal lumen after a 4-week trial. By contrast, Lilleeng et al. (2007) reported that trypsin activity in the IC of the proximal and mid-intestine of Salmo salar remained signi¢cantly lower after 28 days of feeding on a diet with 30% inclusion of soybean meal (7 g TIA kg À 1 feed), while Olli et al. (1994) found that the increase in dietary SBTI caused apparent exhaustion of trypsin-synthesizing capacity in this species. In the case of S. aurata, the results obtained could be explained by a positive feedback regulation in the mechanism of protease secretion to counteract the reduction in digestion capacity when protease inhibitors are included in the diet Haard, Dimes, Arndt & Dong 1996) . In mammals, it was shown that proteolytic activity increased in the gut after SBTI administration (Liddle 1995; Wang, Prpic, Green, Reeve & Liddle 2002) . This fact seems to be mediated by a concurrent cholescystokinin (CCK) secretion stimulated by this protease inhibitor. The release of CCK in the in vivo situation is under negative feedback regulation by proteases present in pancreatic secretion. Active proteases in the intestinal lumen inhibit CCK secretion. The release of CCK is stimulated by a luminal CCK releasing factor (LCRF) that binds to receptors on the secreting cells of the gut. It was shown that under a basal condition, the LCRF is broken down by trypsin and no CCK is secreted. Inhibition of intestinal proteases results in the stimulation of CCK secretion and a subsequent increase in the levels of pancreatic enzymes (Green & Lyman1972) . Taking this into account, the increase in the intestinal protease activity in sea bream fed on SBTI-supplemented diets at day 30 could thus be explained, but to date, it remains unclear in this species and requires further research. No explanation has been found for changes in acid protease activity between the two sampling points in the present study. Sveier et al. (2001) reported that proteolytic activity in the stomach of S. salar fed on high levels of potato protease inhibitor decreased after a 21-day period. However, these authors did not provide any explanation for this fact. Undoubtedly, inhibition of stomach proteases by soybean inhibitor must be discarded, because SBTI-supplemented diets did not a¡ect ¢sh acid proteases (Fig. 1) . In rats, it has been reported that SBTI stimulates the secretion of gastrin (Temler, Dormond, Simon & Morel 1985) . Johnson (2001) indicates that gastrin could in£uence the secretion of pepsinogen. In the case of sea bream, it can be hypothesized that these variations could be caused by negative feedback due to the presence of an inhibitor at the intestinal level, but further research is needed to clarify this point.
A progressive reduction in the alkaline proteolytic activity was found in the trial, with S15 extracts showing a higher proteolytic activity than those for S30 ones. Olli et al. (1994) described the same ¢ndings for S. salar fed on SBTI-supplemented diets. In their study, trypsin activity in the same intestinal segment increased along the sampling time (12 and 31 days), independent of the presence or absence of a protease inhibitor. Obviously, these variations are in£uenced by the continuous growth of digestive organs in juvenile ¢sh, which in£uence protease activity depending on the sampling time point. Keeping this in mind, differences in protease activity among sampling times could be due to both digestive growth and/or the presence of protease inhibitor in the diet, thus not allowing clear conclusions when comparing activities from di¡erent sampling days.
Alkaline protease activity was di¡erent between intestinal segments and, in general, higher values were reported in the DI. The distribution of digestive enzymes along the intestine of sea bream does not seem to be speci¢c for any part of the gut, the distal intestine being characterized by a higher proteolytic activity. This pattern of distribution of digestive proteases seems to be speci¢c for S. aurata as Psochiou, Mamuris, Panagioataki, Kounetas and Moutou (2007) described.
The present study shows that the administration of SBTI-supplemented diets caused no histopathologic alterations during a 30-day period. This agrees with many trials where no di¡erences in gut appearance were reported. For instance, the intestinal histology of Egyptian sole revealed no signi¢cant di¡erences between ¢sh fed on a ¢sh-meal-based diet and a diet containing 300 g kg À 1 soybean meal during an 87-day feeding trial (Bonaldo, Roem, Pecchini, Grilli & Gatta 2006) . Neither Atlantic halibut fed on 360 g kg À 1 soybean-meal diets nor channel cat¢sh fed on a diet with 450 g kg À 1 soybean meal showed intestinal changes after a 60-day trial (GrisdaleHelland, Helland, Baeverfjord & Berge 2002) . On the contrary, our results contrast with many other reports where severe histological alterations are related to the presence of soybean antinutritional factors. Thus, Krogdahl et al. (2003) found histopathologic changes in salmon intestine due to the inclusion of 100 g kg À 1 of soybean meal in a 60-day feeding experiment. Bonaldo et al. (2008) reported morphological alterations in the distal intestine of sea bream fed on a diet with 300 g kg À 1 of soybean meal for 80 days. Furthermore, Lilleeng et al. (2007) described enteritis in the distal intestine of salmon fed on a soybean diet for 28 days. Boonyaratpalin, Suraneiranat and Tunpinabal (1998) described highly vacuolated enterocytes with eosinophilic inclusion in Asian sea bass fed on an extruded soybean-meal diet for 10 weeks. The present results, showing no intestinal histological modi¢cations, can therefore be attributed to the speci¢c sensitivity of certain ¢sh species. Another possible explanation is that gut morphological changes described by other authors may have been caused by the presence of lectins, allergenic proteins or alcohol soluble components present in soybean instead of the protease inhibitor tested in this work (Van Den Ingh, Olli & Krogdahl 1996; Francis et al. 2001) . The results obtained in this study show that SBTI do not produce enterocyte and gut morphological alterations during mid-term feeding periods.
Conclusion
The inclusion of up to 4.0 g kg À 1 SBTI (i) reduces sea bream intestinal proteolytic activity at the beginning of its administration through the formation of highmolecular-weight complexes with serine proteases (although sea bream juveniles are able to overcome protease inhibitor e¡ects within a 30-day feeding trial) and (ii) does not a¡ect intestinal histology. At the end of the trial, ¢sh fed on SBTI-supplemented diets showed ¢nal weights, proteolytic activities and intestinal histological appearance similar to those found in ¢sh fed on the inhibitor-free diet.
